Skip to content

Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone

A Prospective, Open, Single Arm, Multi-center Study to Evaluate Maintenance of Lingual Bone in Healed Ridges With the ASTRA TECH Implant System, OsseoSpeed™ Profile Implant. A 3-year Follow-up Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00807456
Enrollment
65
Registered
2008-12-12
Start date
2008-11-30
Completion date
2013-12-31
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulism

Brief summary

The study aims to evaluate maintenance of lingual/palatinal marginal bone with the (ASTRA TECH Implant System) OsseoSpeed™ Profile implant in sites where the alveolar crest anatomy is sloped in a lingual to buccal direction. The hypothesis is that the sloped marginal contour of the implant will help preserve the lingual/palatinal marginal bone.

Interventions

ASTRA TECH Implant System, OsseoSpeed™ Profile implants: Ø4.5, 5.0, 5.0S mm in lengths of 9, 11, 13, 15mm.

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Provision of informed consent * Aged 18-75 years at enrolment * A lingual-buccal difference in bone height between 2.0-5.0 mm at the implant site * History of edentulism in the study area of at least 3 months * Presence of alveolar bone crest dimensions judged by the investigator to allow ≥1mm of bone circumferential to the implant after implant placement. * In need for a single implant replacing a missing tooth in any location with an adjacent natural tooth mesially, and an adjacent natural tooth or edentulous space distally to the planned implant position (i.e. no existing or planned implant adjacent to the planned study implant position) * Deemed by the investigator as likely to present an initially stable implant situation

Exclusion criteria

* Uncontrolled pathological processes in the oral cavity * Known or suspected current malignancy * History of radiation therapy in the head and neck region * History of chemotherapy within 5 years prior to surgery * Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration * Uncontrolled diabetes mellitus * Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration * Smoking more than 10 cigarettes per day * Present alcohol and/or drug abuse * Current need for bone grafting in the planned implant area * Previous enrolment in the present study * Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months * Involvement in the planning and conduct of the study (applies to both Sponsor staff or staff at the study site) * Unlikely to be able to comply with study procedures, as judged by the investigator

Design outcomes

Primary

MeasureTime frameDescription
Bone Level Changes at the Lingual Aspect From Implant Placement (Baseline) to Re-entry 16 Weeks After Implant PlacementAt baseline and 16 weeksClinical measurements after implant installation and after 16 weeks to determine bone levels at the buccal and lingual aspects in relation to a fixed landmark on the implant, i.e. the interface between the micro-threaded part and the shoulder at the marginal portion of the implants.The assessments were made using a periodontal probe and distances were measured to the nearest 0.5 mm. Negative value denotes loss of bone.

Secondary

MeasureTime frameDescription
Implant Survival Rate21 weeks, 12 months, 24 months and 36 months post implant placement.The survival rate for individual implants was evaluated at each visit. Any removed implant was considered an implant loss, regardless of reason for removal.
Marginal Bone Level (MBL) Change From Implant Placement Presented on Implant LevelBaseline and 16 weeks, 21 weeks, 12 months, and 36 months post implant placementMBL alteration assessed by measuring the distance from the implant reference point to the most conical bone-to-implant contact on the mesial and distal side of the implant. The mean of all values for one subject was calculated and used for analysis.
Condition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)21 weeks, 12 months, 24 months, and 36 months post implant placementBoP was assessed by recording bleeding after probing at the mesial, distal, buccal, and palatal surfaces of the implant site.
Condition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent RestorationBaseline and 12 months, 24 months, and 36 months post implant placementPPD was measured using a regular peridontal probe from the gingival margin to nearest whole millimeter. The average PPD change from permanent restoration is presented on implant level.
Condition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent RestorationBaseline and 12 months, 24 months, and 36 months post implant placementCAL was measure with a probe from the crown margin (the interface between the abutment) to the crown at the mesial, buccal, distal, and lingual aspects of the implant. The average CAL change from permanent restoration is presented on implant level.

Countries

Germany, Italy, United States

Participant flow

Participants by arm

ArmCount
Subjects Treated With ASTRA TECH Implant System, OsseoSpeed™ Profile Implant
ASTRA TECH Implant System, OsseoSpeed™: ASTRA TECH Implant System, OsseoSpeed™ Profile implants: Ø4.5, 5.0, 5.0S mm in lengths of 9, 11, 13, 15mm.
65
Total65

Baseline characteristics

CharacteristicSubjects Treated With ASTRA TECH Implant System, OsseoSpeed™ Profile Implant
Age, Continuous49.05 years
STANDARD_DEVIATION 13.974
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 65
other
Total, other adverse events
0 / 65
serious
Total, serious adverse events
2 / 65

Outcome results

Primary

Bone Level Changes at the Lingual Aspect From Implant Placement (Baseline) to Re-entry 16 Weeks After Implant Placement

Clinical measurements after implant installation and after 16 weeks to determine bone levels at the buccal and lingual aspects in relation to a fixed landmark on the implant, i.e. the interface between the micro-threaded part and the shoulder at the marginal portion of the implants.The assessments were made using a periodontal probe and distances were measured to the nearest 0.5 mm. Negative value denotes loss of bone.

Time frame: At baseline and 16 weeks

Population: Per-protocol analysis set

ArmMeasureValue (MEAN)Dispersion
Subjects Treated With OsseoSpeed™ Profile ImplantBone Level Changes at the Lingual Aspect From Implant Placement (Baseline) to Re-entry 16 Weeks After Implant Placement-0.02 mmStandard Deviation 0.49
Secondary

Condition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent Restoration

CAL was measure with a probe from the crown margin (the interface between the abutment) to the crown at the mesial, buccal, distal, and lingual aspects of the implant. The average CAL change from permanent restoration is presented on implant level.

Time frame: Baseline and 12 months, 24 months, and 36 months post implant placement

Population: Per-protocol analysis set. All subjects available for each visit are included in below analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent RestorationPermanent restoration to 12 months post implant placement0.02 CAL in mmStandard Deviation 0.54
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent RestorationPermanent restoration to 24 months post implant placement0.14 CAL in mmStandard Deviation 0.57
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent RestorationPermanent restoration to 36 months post implant placement0.11 CAL in mmStandard Deviation 0.85
Secondary

Condition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent Restoration

PPD was measured using a regular peridontal probe from the gingival margin to nearest whole millimeter. The average PPD change from permanent restoration is presented on implant level.

Time frame: Baseline and 12 months, 24 months, and 36 months post implant placement

Population: Per-protocol analysis set. All subjects available for each visit are included in below analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent RestorationPermanent restoration to 12 months post implant placement0.28 PPD in mmStandard Deviation 0.73
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent RestorationPermanent restoration to 24 months post implant placement0.31 PPD in mmStandard Deviation 0.68
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent RestorationPermanent restoration to 36 months post implant placement0.36 PPD in mmStandard Deviation 0.85
Secondary

Condition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)

BoP was assessed by recording bleeding after probing at the mesial, distal, buccal, and palatal surfaces of the implant site.

Time frame: 21 weeks, 12 months, 24 months, and 36 months post implant placement

Population: Per-protocol analysis set. All subjects available for each visit are included in below analyses.

ArmMeasureGroupValue (NUMBER)
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)Permanent restoration 21 weeks after implant placement2 Implants with BoP
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)12 months after implant placement20 Implants with BoP
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)24 months after implant placement16 Implants with BoP
Subjects Treated With OsseoSpeed™ Profile ImplantCondition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)36 months after implant placement21 Implants with BoP
Secondary

Implant Survival Rate

The survival rate for individual implants was evaluated at each visit. Any removed implant was considered an implant loss, regardless of reason for removal.

Time frame: 21 weeks, 12 months, 24 months and 36 months post implant placement.

Population: Per-protocol analysis set

ArmMeasureValue (COUNT_OF_UNITS)
Subjects Treated With OsseoSpeed™ Profile ImplantImplant Survival Rate65 Implants
Subjects Assessed at 12 Months Post Implant PlacementImplant Survival Rate64 Implants
Subjects Assessed at 24 Months Post Implant PlacementImplant Survival Rate59 Implants
Subjects Assessed at 36 Months Post Implant PlacementImplant Survival Rate57 Implants
Secondary

Marginal Bone Level (MBL) Change From Implant Placement Presented on Implant Level

MBL alteration assessed by measuring the distance from the implant reference point to the most conical bone-to-implant contact on the mesial and distal side of the implant. The mean of all values for one subject was calculated and used for analysis.

Time frame: Baseline and 16 weeks, 21 weeks, 12 months, and 36 months post implant placement

Population: Per-protocol analysis set. All subjects/implants available for each visit are included in below analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Subjects Treated With OsseoSpeed™ Profile ImplantMarginal Bone Level (MBL) Change From Implant Placement Presented on Implant LevelImplant Placement to re-entry (implant placement + 16 weeks)-0.28 mmStandard Deviation 0.68
Subjects Treated With OsseoSpeed™ Profile ImplantMarginal Bone Level (MBL) Change From Implant Placement Presented on Implant LevelImplant placement to permanent restoration (implant placement + 21 weeks)-0.48 mmStandard Deviation 0.74
Subjects Treated With OsseoSpeed™ Profile ImplantMarginal Bone Level (MBL) Change From Implant Placement Presented on Implant LevelImplant placement to implant placement + 12 months-0.29 mmStandard Deviation 1.1
Subjects Treated With OsseoSpeed™ Profile ImplantMarginal Bone Level (MBL) Change From Implant Placement Presented on Implant LevelImplant placement to implant placement + 36 months-0.57 mmStandard Deviation 1.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026